<DOC>
	<DOCNO>NCT00622440</DOCNO>
	<brief_summary>The purpose study find Chinese herbal cream effective treating HSIL ( high-grade squamous intraepithelial lesion , also know HGAIN , high-grade anal intraepithelial neoplasia ) .</brief_summary>
	<brief_title>Treatment Anal High-grade Squamous Intraepithelial Lesions ( HSIL ) Through Use Chinese Herbal Topical Cream</brief_title>
	<detailed_description>The purpose study test new noninvasive topical cream , AIJP ( Arnebia Indigo Jade Pearl ) , treatment precancerous anal lesion order prevent progression anal cancer . AIJP topical Chinese herbal cream specifically design treat people cancer precursor lesion cause human papillomavirus ( HPV ) . In general , HPV infection key factor development cervical , anal vulvar cancer . People HIV especially vulnerable develop anal cancer associate HPV . It known prior development anal cancer person develop precancerous condition know high-grade squamous intraepithelial lesion ( HSIL ) . Treatment HSIL prevent progression anal cancer . Current therapy HSIL anal cancer highly invasive . A new effective noninvasive topical therapy precancerous HSIL could high impact prevention anal cancer .</detailed_description>
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<mesh_term>Anus Neoplasms</mesh_term>
	<criteria>Anal HSIL confirm biopsy 30 day prior entry Anal HSIL deem amenable therapy participant decline routine ablative therapy HIV positive Stable HIV treatment regimen least 8 week prior entry At least 18 year age Women childbearing potential must use contraception Platelet count 70,000/mm3 within 30 day prior entry ANC great equal 1000/mm3 within 30 day prior entry Creatinine less equal 1.5 time ULN within 30 day prior entry AST ALT less equal 3 time ULN within 30 day prior entry Prior history invasive anal , cervical , vaginal , vulvar cancer Pregnancy lactation breastfeed Must participate conception process include sperm donation Medical psychiatric illness precludes ability give inform consent likely interfere ability comply protocol Known allergy topical cream component Patients lesion clinically suspicious per HRA examiner early progression ( less one year ) anal cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>HSIL</keyword>
	<keyword>HGAIN</keyword>
	<keyword>AIN</keyword>
	<keyword>neoplasia</keyword>
	<keyword>dysplasia</keyword>
	<keyword>TCM</keyword>
	<keyword>Traditional Chinese Medicine</keyword>
</DOC>